Xcell Therapeutics엑셀세라퓨틱스
373110 · KOSDAQ · ₩373110 · 엑셀세라퓨틱스
₩973▼ ₩25 (2.51%)End-of-day · Oct 30, 2026 · End-of-day prices.
Filings
- 5%+ holding report주식등의대량보유상황보고서(일반)Oct 27, 2026Open on DART
Predicted impact: Low
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 23, 2026Open on DART
Predicted impact: Low
- Other Market Notice (Potential Designation as Administrative Issue – Market Capitalization Below ₩20B)기타시장안내(관리종목지정우려종목) (시가총액 200억원 미달)Oct 12, 2026Open on DART
Predicted impact: Medium· Actual: −1.2% vs sector, volume 1.4× normal (5 trading days)
Market cap below ₩20B raises possible administrative issue designation for a small biotech.
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Sep 11, 2026Open on DART
- Half-year report (Jun 2026)반기보고서 (2026.06)Aug 14, 2026Open on DART
- Preliminary earnings (consolidated)연결재무제표기준영업(잠정)실적(공정공시)Aug 6, 2026Open on DART
- Quarterly report (Mar 2026)분기보고서 (2026.03)May 15, 2026Open on DART
- Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)May 15, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Apr 15, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 1, 2026Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Apr 1, 2026Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Apr 1, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 30, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 30, 2026Open on DART
- Annual general meeting results정기주주총회결과Mar 27, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 27, 2026Open on DART
- Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 20, 2026Open on DART
- Audit report submitted감사보고서제출Mar 19, 2026Open on DART
- Annual report (Dec 2025)사업보고서 (2025.12)Mar 19, 2026Open on DART
- Notice of Reason for Concentrated Shareholders' Meeting Date주주총회집중일개최사유신고Mar 11, 2026Open on DART
- Shareholders' meeting called주주총회소집결의Mar 11, 2026Open on DART
- Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 11, 2026Open on DART
- Notice of shareholders' meeting주주총회소집공고Mar 11, 2026Open on DART
- Merger Completion Report (Asset Acquisition and Transfer)합병등종료보고서(자산양수도)Mar 5, 2026Open on DART
- [Amended Filing] Major Matters Report (Decision on Transfer of Equity Securities of Another Company)[기재정정]주요사항보고서(타법인주식및출자증권양도결정)Mar 5, 2026Open on DART
- Major Matters Report (Decision on Transfer of Equity Securities of Another Company)주요사항보고서(타법인주식및출자증권양도결정)Mar 3, 2026Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 13, 2026Open on DART
- Investor relations (IR) event기업설명회(IR)개최Dec 16, 2025Open on DART
- Determination of Shareholder Register Closure Period or Record Date주주명부폐쇄기간또는기준일설정Dec 15, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Nov 28, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 28, 2025Open on DART
- Amended: 5%+ holding report[기재정정]주식등의대량보유상황보고서(일반)Nov 28, 2025Open on DART
- Securities Issuance Results (Voluntary Disclosure) (Rights Offering Followed by General Public Offering of Unsubscribed Shares)증권발행결과(자율공시) (유상증자(주주배정 후 실권주 일반공모))Nov 20, 2025Open on DART
- Securities Issuance Results Report증권발행실적보고서Nov 20, 2025Open on DART
- Subscription Results for Rights Offering or Equity-Linked Bonds (Voluntary Disclosure) (General Public Offering of Shares Not Subscribed in Shareholder Allotment)유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)Nov 19, 2025Open on DART
- Subscription Results for Rights Offering or Equity-Linked Bonds (Voluntary Disclosure) (General Public Offering of Shares Not Subscribed in Shareholder Allotment)유상증자또는주식관련사채등의청약결과(자율공시) (주주배정후 실권주 일반공모)Nov 14, 2025Open on DART
- Quarterly report (Sep 2025)분기보고서 (2025.09)Nov 14, 2025Open on DART
- Final Determination of Issue Price for Rights Offering유상증자최종발행가액확정Nov 10, 2025Open on DART
- Amended: Prospectus[기재정정]투자설명서Nov 10, 2025Open on DART
- Terms set: Securities registration statement[발행조건확정]증권신고서(지분증권)Nov 10, 2025Open on DART
- Amended: Rights offering (paid-in capital increase) decision[기재정정]주요사항보고서(유상증자결정)Nov 10, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 7, 2025Open on DART
- 5%+ holding report주식등의대량보유상황보고서(일반)Nov 3, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Nov 3, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 21, 2025Open on DART
- Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Oct 21, 2025Open on DART
- Ex-Rights Date (Rights Offering)권리락 (유상증자)Sep 30, 2025Open on DART
Titles in Korean until English translations are added.
Also known as: Xcell Therapeutics / 엑셀세라퓨틱스 / 373110 / KRX:373110
Source: KRX statistical information